Leaflet APREXEVO 300mg / 10mg film-coated tablets

Product code:
W66859003
Quantity:
30
Indicated for:
hypertension
Route of administration:
oral
Substance:
irbesartan + amlodipine (angiotensin II receptor blocker + calcium channel blocker)
ATC
C09DB05 — Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers

Precautions:

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances

This medicine may change blood electrolyte levels.

The combination of irbesartan and amlodipine is used to treat high blood pressure in patients who do not respond adequately to monotherapy. Irbesartan is an angiotensin II receptor antagonist that helps relax blood vessels, while amlodipine is a calcium channel blocker that lowers blood pressure by relaxing the muscles of blood vessels.

The medication is taken orally, usually once daily, as directed by a doctor.

Side effects may include dizziness, edema, fatigue, or nausea. In rare cases, severe allergic reactions or kidney dysfunction may occur.

Patients should inform their doctor about any other medications they are taking and strictly follow the treatment regimen. Pregnant or breastfeeding women should not use this medication.

General data about APREXEVO 300mg / 10mg

Substance:
irbesartan + amlodipine
Date of latest medicines list:
01-09-2023
Product code:
W66859003
Concentration:
300mg / 10mg
Pharmaceutical form:
film-coated tablets
Quantity:
30
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
ZENTIVA S.A. - ROMANIA
Holder:
SANOFI ROMANIA SRL - ROMANIA
Number:
13284/2020/03
Shelf life:
3 years

Concentrations available for irbesartan + amlodipine

  • 150mg/10mg
  • 150mg/5mg
  • 300mg/10mg
  • 300mg/5mg